Rohto Pharmaceutical Co.,Ltd. (TYO:4527)

Rohto Pharmaceutical Revenue

In the fiscal year ending March 31, 2026, Rohto Pharmaceutical had annual revenue of 343.73B JPY with 11.37% growth. Rohto Pharmaceutical had revenue of 90.65B in the quarter ending March 31, 2026, with 9.58% growth.

• Revenue: 343.73B
• Revenue Growth: +11.37%
• P/S Ratio: 1.53
• Revenue / Employee: 37.59M
• Employees: 9,144
• Market Cap: 525.25B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	343.73B	35.10B	11.37%
Mar 31, 2025	308.63B	37.79B	13.95%
Mar 31, 2024	270.84B	32.18B	13.48%
Mar 31, 2023	238.66B	39.02B	19.54%
Mar 31, 2022	199.65B	18.36B	10.13%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error